Approvals/TGA/RIFADIN rifampicin 600mg powder for injection vial with diluent ampoule

Approved

STANDARD

RIFADIN rifampicin 600mg powder for injection vial with diluent ampoule

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 28a8aa3dd9825fa1
Product Name: RIFADIN rifampicin 600mg powder for injection vial with diluent ampoule
Artg Id: 156919
Artg Name: RIFADIN rifampicin 600mg powder for injection vial with diluent ampoule
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2009-01-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/344aa4b153f35fab8260cec25ca189bf.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/98ca4d3ab15bef304839254546b5aa37.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

28a8aa3dd9825fa1

Type

Standard